- SUBSTITUTED PIPERIDINE COMPOUNDS
-
The present disclosure provides substituted piperidine compounds having Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein R1, B, X, and Z are defined as set forth in the specification. The present disclosure i
- -
-
-
- Positive allosteric modulators of the nicotinic acetylcholine receptor
-
The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.
- -
-
-
- Isoxazole derivatives
-
Isoxazole derivatives represented by the formula: STR1 are prepared; wherein R1 and R2 each is hydrogen atom, alkyl group of 1 to 8 carbon atoms, or cycloalkyl group of 3 to 10 carbon atoms; R3 and R4 each is hydrogen atom, alkyl group of 1 to 8 carbon atoms, cycloalkyl group of 3 to 10 carbon atoms, or phenyl group; or the group Is morpholino group; and Y is oxo group, thioxo group or imino group; being useful as a hypoglycemic and/or a blood free-fatty-acid normalizing antidiabetic agent.
- -
-
-